Literature DB >> 3058473

Familial polycystic ovarian disease.

J R Givens1.   

Abstract

Emphasis is placed on the heterogeneity of the phenotypic presentation of PCOD. It is the common expression of an unknown number of disorders and thus is a sign and not a specific diagnosis. Two essential features are arrested follicular maturation and atresia of follicles. Normal folliculogenesis is described, emphasizing that a large number of areas could be subject to derangement causing PCOD. Any interference of the finely balanced sequence of events can lead to PCOD. The genetic defect causing familial PCOD is unknown and the initiating event remains undefined. Three families are described that illustrate four features of familial PCOD. A number of associated disorders such as diabetes, hyperinsulinemia, obesity, and hypertension are described. The potential importance of agents that modulate the LH and FSH activity that may cause PCOD is emphasized. The theoretic means by which similar male and female gonadal abnormalities may be coupled in families through growth factors EGF and alpha TGF are presented.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058473

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  18 in total

1.  Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance.

Authors:  E Diamanti-Kandarakis; K Alexandraki; A Bergiele; H Kandarakis; G Mastorakos; A Aessopos
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

2.  Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.

Authors:  D M Liu; L C Torchen; Y Sung; R Paparodis; R S Legro; S K Grebe; R J Singh; R L Taylor; A Dunaif
Journal:  Hum Reprod       Date:  2014-10-21       Impact factor: 6.918

Review 3.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

4.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

Authors:  M Urbanek; R S Legro; D A Driscoll; R Azziz; D A Ehrmann; R J Norman; J F Strauss; R S Spielman; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

5.  Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.

Authors:  Susan Sam; Richard S Legro; Rhonda Bentley-Lewis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2005-05-17       Impact factor: 5.958

6.  Genetics of polycystic ovary syndrome.

Authors:  N Prapas; A Karkanaki; I Prapas; I Kalogiannidis; I Katsikis; D Panidis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 8.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

9.  Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Yeon-Ah Sung; Richard S Legro; Andrea Dunaif
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

10.  Does PCOS have developmental origins?

Authors:  Stephen Franks; Sarah L Berga
Journal:  Fertil Steril       Date:  2012-01       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.